Status:
TERMINATED
Keloid Tissue Bank
Lead Sponsor:
Tirgan, Michael H., M.D.
Conditions:
Keloid
Eligibility:
All Genders
13+ years
Brief Summary
Much progress in treatment of various tumors has been made in the laboratory and the results have been brought back to the patients, i.e. from bench to bedside. This trial intends to collect samples o...
Detailed Description
To aims of this trial are: 1. To prospectively collect keloid and normal skin tissue samples from patients with keloid by performing keloid tissue biopsy and biopsy of uninvolved skin. 2. To collect ...
Eligibility Criteria
Inclusion
- Patients must have clinically confirmed diagnosis of keloid
- Signed consent form; parent or a legal guardian should consent for children and those under age of 18.
- Have at least one paraffin block of excess keloid tissue that has been removed in the past; or is planned to be removed in future.
- Able and willing to undergo a keloid biopsy (optional)
- Able and willing to undergo biopsy of their normal appearing skin (optional, minimum age 18).
Exclusion
- Individuals who are mentally challenged, who cannot consent to participate in this study.
- Psychological Illness that may result in non-compliance with the procedure and the required follow up.
- Known allergy to lidocaine or other local anesthetics.
Key Trial Info
Start Date :
June 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT01425437
Start Date
June 1 2012
End Date
December 1 2018
Last Update
November 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michael H. Tirgan, MD
New York, New York, United States, 10023